188 related articles for article (PubMed ID: 28127738)
1. The role of RANKL/RANK/OPG system in the canine model of hip periprosthetic infection osteolysis.
Zhang HW; Peng L; Li WB; Song KG
Int J Artif Organs; 2017 Feb; 39(12):619-624. PubMed ID: 28127738
[TBL] [Abstract][Full Text] [Related]
2. Receptor activator of nuclear factor kappaB ligand is expressed in resident and inflammatory cells in aseptic and septic prosthesis loosening.
Gehrke T; Sers C; Morawietz L; Fernahl G; Neidel J; Frommelt L; Krenn V
Scand J Rheumatol; 2003; 32(5):287-94. PubMed ID: 14690142
[TBL] [Abstract][Full Text] [Related]
3. Alteration of the RANKL/RANK/OPG System in Periprosthetic Osteolysis with Septic Loosening.
Wang L; Dai Z; Xie J; Liao H; Lv C; Hu Y
Inflammation; 2016 Feb; 39(1):218-227. PubMed ID: 26294373
[TBL] [Abstract][Full Text] [Related]
4. Serum levels of osteoprotegerin and receptor activator of nuclear factor-kappaB ligand as markers of periprosthetic osteolysis.
Granchi D; Pellacani A; Spina M; Cenni E; Savarino LM; Baldini N; Giunti A
J Bone Joint Surg Am; 2006 Jul; 88(7):1501-9. PubMed ID: 16818976
[TBL] [Abstract][Full Text] [Related]
5. [EXPRESSION OF RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-κB LIGAND IN PERIPHERAL BLOOD OF PATIENTS WITH ASEPTIC LOOSENING OF THE IMPLANT AFTER TOTAL HIP APTHROPLASTY].
Hou K; Wang Y; Lu X; Yang K; Kong W; Li Y
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Jul; 28(7):853-6. PubMed ID: 26462349
[TBL] [Abstract][Full Text] [Related]
6. Over-expression of receptor activator of nuclear factor-kappaB ligand (RANKL), inflammatory cytokines, and chemokines in periprosthetic osteolysis of loosened total hip arthroplasty.
Wang CT; Lin YT; Chiang BL; Lee SS; Hou SM
Biomaterials; 2010 Jan; 31(1):77-82. PubMed ID: 19781765
[TBL] [Abstract][Full Text] [Related]
7. [The participation of RANK, RANKL and OPG in tumor osteolysis].
Stanisławowski M; Kmieć Z
Postepy Hig Med Dosw (Online); 2009 May; 63():234-41. PubMed ID: 19502684
[TBL] [Abstract][Full Text] [Related]
8. Naringin increases osteoprotegerin expression in fibroblasts from periprosthetic membrane by the Wnt/β-catenin signaling pathway.
Yang C; Liu W; Zhang X; Zeng B; Qian Y
J Orthop Surg Res; 2020 Dec; 15(1):600. PubMed ID: 33302980
[TBL] [Abstract][Full Text] [Related]
9. Melittin Treats Periprosthetic Osteolysis in a Rat Model by Inhibiting the NF-kB Pathway and Regulating the Ratio of Receptor Activator of Nuclear Factor Kappa B Ligand/Osteoprotegerin.
Niu J; Bi F; Tian Q; Tian K
J Arthroplasty; 2024 Jul; 39(7):1845-1855. PubMed ID: 38336308
[TBL] [Abstract][Full Text] [Related]
10. Alendronate stimulates osteoprotegerin expression in fibroblasts from periprosthetic membrane.
Qian Y; Zhang XL; Jiang Y; Zeng BF; Wang Q; Chen Y; Shen H; Wang Q
Hip Int; 2015; 25(6):581-4. PubMed ID: 26351115
[TBL] [Abstract][Full Text] [Related]
11. Periprosthetic osteolysis and its association with RANKL expression.
Veigl D; Niederlová J; Kryštůfková O
Physiol Res; 2007; 56(4):455-462. PubMed ID: 16925460
[TBL] [Abstract][Full Text] [Related]
12. Expression and Distribution of Receptor Activator of Nuclear Factor Kappa B, Receptor Activator of Nuclear Factor Kappa B Ligand, and Osteoprotegerin in Periradicular Cysts.
Armada L; Marotta Pdos S; Pires FR; Siqueira JF
J Endod; 2015 Aug; 41(8):1281-7. PubMed ID: 25956608
[TBL] [Abstract][Full Text] [Related]
13. The role of RANK/RANKL/OPG signalling pathways in osteoclastogenesis in odontogenic keratocysts, radicular cysts, and ameloblastomas.
Tekkesin MS; Mutlu S; Olgac V
Head Neck Pathol; 2011 Sep; 5(3):248-53. PubMed ID: 21643971
[TBL] [Abstract][Full Text] [Related]
14. Interface tissue fibroblasts from loose total hip replacement prosthesis produce receptor activator of nuclear factor-kappaB ligand, osteoprotegerin, and cathepsin K.
Mandelin J; Li TF; Hukkanen M; Liljeström M; Salo J; Santavirta S; Konttinen YT
J Rheumatol; 2005 Apr; 32(4):713-20. PubMed ID: 15801030
[TBL] [Abstract][Full Text] [Related]
15. RANK, RANKL and OPG in inflammatory arthritis and periprosthetic osteolysis.
Ritchlin CT; Schwarz EM; O'Keefe RJ; Looney RJ
J Musculoskelet Neuronal Interact; 2004 Sep; 4(3):276-84. PubMed ID: 15615495
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-34a alleviates steroid-induced avascular necrosis of femoral head by targeting Tgif2 through OPG/RANK/RANKL signaling pathway.
Peng WX; Ye C; Dong WT; Yang LL; Wang CQ; Wei ZA; Wu JH; Li Q; Deng J; Zhang J
Exp Biol Med (Maywood); 2017 Jun; 242(12):1234-1243. PubMed ID: 28454497
[TBL] [Abstract][Full Text] [Related]
17. Expression of RANKL in osteolytic membranes: association with fibroblastic cell markers.
Ramage SC; Urban NH; Jiranek WA; Maiti A; Beckman MJ
J Bone Joint Surg Am; 2007 Apr; 89(4):841-8. PubMed ID: 17403809
[TBL] [Abstract][Full Text] [Related]
18. (5R)-5-Hydroxytriptolide (LLDT-8) inhibits osteoclastogenesis via RANKL/RANK/OPG signaling pathway.
Shen Y; Jiang T; Wang R; He S; Guo M; Zuo J; He D
BMC Complement Altern Med; 2015 Mar; 15():77. PubMed ID: 25887296
[TBL] [Abstract][Full Text] [Related]
19. Effects of Wenyangbushen formula on the expression of VEGF, OPG, RANK and RANKL in rabbits with steroid-induced femoral head avascular necrosis.
Song HM; Wei YC; Li N; Wu B; Xie N; Zhang KM; Wang SZ; Wang HM
Mol Med Rep; 2015 Dec; 12(6):8155-61. PubMed ID: 26496816
[TBL] [Abstract][Full Text] [Related]
20. Expression profile of osteoprotegerin, RANK and RANKL genes in the femoral head of patients with avascular necrosis.
Samara S; Dailiana Z; Chassanidis C; Koromila T; Papatheodorou L; Malizos KN; Kollia P
Exp Mol Pathol; 2014 Feb; 96(1):9-14. PubMed ID: 24200492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
